Carnitine Palmitoyltransferase 2, Mitochondrial (CPT2) Peptide
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Carnitine Palmitoyltransferase 2, Mitochondrial (CPT2) Peptide is a synthetic peptide.
Documents del producto
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Carnitine Palmitoyltransferase 2, Mitochondrial (CPT2) |
| Host | Synthetic |
| Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Observed MW | Sequence Fragment: Internal region, 406-418 AA: C-TDSTVTVQKLNFE |
| Size 1 | 100 µg |
| Form | Lyophilized Reconstitute in deionized water. |
| Tested Applications | P-ELISA |
| Buffer | Prior to lyophilization: Deionized water. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 1376 |
| NCBI Accession | NP_000089.1 |
| Background | Protein CPT2 |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products
CPT2 antibody
Ver Producto
Carnitine Palmitoyltransferase 2, Mitochondrial (CPT2) Antibody
CPT2 Antibody is a Rabbit Polyclonal antibody against CPT2. The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders.
Ver Producto
Carnitine Palmitoyltransferase 2, Mitochondrial (CPT2) Antibody
Carnitine palmitoyltransferase II precursor (CPT2) is a nuclear protein which is transported to the mitochondrial inner membrane. CPT2 together with carnitine palmitoyltransferase I oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders.
Ver Producto